Sections & Products

Main > RHEUMATOLOGY>RHEUMATOID ARTHRITIS > Treatment

Treatment's subsections

Activator Protein-1 Inhibitor

AdalimuMAb (Approved)

Bacterial Toxin

CD80 AntAgonists.

Celecoxib (Approved)

CertolizuMAb Pegol (Phase III)

Complement Inhibitors.

Cox-2 Inhibitors (Pain Control)

Device.

DHODH Inhibitors (Vidofludimus)

Etanercept (Approved)

Etoricoxib (Approved>India)

Fostamatinib DiNa (Oral Syk Inh.)

GolimuMAb (Phase III)

HydroxyChloroQuine.

ImmunoSuppressant Therapy

Indolin-2-One Derivatives

InflixiMAb

InterLeukin (IL) Inhibitors

Leflunomide

Lumiracoxib (Approved)

Masitinib (Tyrosine Kinase Inh.)

MetalloProtease Inhibitor

Methotrexate

Monoclonal T Cell Receptor (mTCR)

Nabumetone

Naproxen(NSAID)

Naproxen(NSAID)+EsomeprAzole (PPI)

Naproxen(NSAID)+LansoprAzole (PPI)

NeuroKinin (Substance P) Inhibitors

OfatumuMAb (Phase III)

OsteoProteGerin (Protein)

p38 MAP Kinase Inhibitor Program

Paclitaxel

Prednisone Modified Release (NSAID)

Protein Therapeutics

RANK Ligand (RANKL).

RituxiMAb (Approved)

TachyKinin Receptor Antagonists

Tumor Necrosis Factor Inhibitors

Treatment's products
This section has no products